• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Y

    Yodogawa Christian Hospital

    EST. 1955
    787论文总数
    1.1万引用总数

    Yodogawa Christian Hospital (淀川キリスト教病院, Yodogawa Kirisutokyō byōin) is a Christian hospital in Higashiyodogawa-ku, Osaka, Japan.

    论文量&引用量时间轴

    机构学者

    论文(787)

    年份
    起
    –
    止
    排序
    1Therapeutic Value of Para-Aortic Lymph Node Dissection in Gastric Cancer with Extensive Lymph Node Metastasis: Integrated Analysis of Three Phase II Trials (JCOG2212A).
    Takeyuki Wada, Masayuki Yokoyama,Seiji Ito,Tadayoshi Hashimoto,Kota Kawabata,Kazuhisa Ehara,Takashi Nomura,Masaki Aizawa,Ryohei Kawabata,Daisuke Takahari,Mitsuru Sasako,Akira Tsuburaya,

    BACKGROUND: Japan Clinical Oncology Group (JCOG) defined gastric cancer (GC) with bulky lymph node (Bulky N) and/or para-aortic lymph node (PAN) as extensive lymph node metastasis (ELM), and has developed neoadjuvant chemotherapy followed by D2 gastrectomy with PAN dissection (PAND) through three phase II trials using different regimens (JCOG0001: irinotecan/cisplatin, JCOG0405: cisplatin/S-1, JCOG1002: docetaxel/cisplatin/S-1). However, whether PAND provides survival benefit remains uncertain. METHODS: The therapeutic value index was investigated using integrated data from JCOG0001, JCOG0405, and JCOG1002. Patients were classified into Bulky N group (only bulky N without PAN) and PAN group (PAN regardless of bulky N) based on the clinical diagnosis. The index was calculated by multiplication of incidence of metastasis and percentage 5-year relapse-free survival (5yRFS) of patients with metastasis for each lymph node area. RESULTS: A total of 122 patients were analyzed (Bulky N group: 68, PAN group: 54). In Bulky N group, the proportion of metastasis/5yRFS/index in the PAN area was 15.2%/30.0%/4.5 (JCOG0001: 27.8%/20.0%/5.6, JCOG0405: 13.6%/33.3%/4.5, JCOG1002: 7.7%/50.0%/3.8). The proportion of metastasis decreased across trials. In PAN group, the proportion of metastasis/5yRFS/index in the PAN area was 44.4%/4.2%/1.9 (JCOG0001: 81.3%/7.7%/6.3, JCOG0405: 30.0%/0.0%/0.0, JCOG1002: 27.8%/0.0%/0.0). Notably, the indices of the recent two trials were zero. CONCLUSIONS: PAND may retain a potential role in the Bulky N group, whereas its benefit appears limited in the PAN group. Decreasing trends in PAN metastasis and therapeutic value were observed in both groups. Given the distinct characteristics of these subgroups, the omission of PAND should be determined through separate future validation.

    2026Gastric Cancer(2026)引用:18
    引用
    AI阅读
    加入学术空间
    2Long-term Outcomes Remain Unchanged Despite Reduced Glucocorticoid Exposure in ANCA-associated Vasculitis: the Multicentre REVEAL Cohort Study
    Mayu Shiomi,Ryu Watanabe,Muneyuki Hatta,Shogo Matsuda,Takuya Kotani,Ayana Okazaki, Yuichi Masuda, Mikihito Shoji,Atsushi Manabe,Keiichiro Kadoba, Tsuneyasu Yoshida, Naoko Ito,

    BackgroundThe long-term prognosis of patients with anti-neutrophil cytoplasmic antibody–associated vasculitis (AAV) has historically been poor. In recent years, the widespread use of novel targeted therapies has led to an increased emphasis on reduced-dose glucocorticoid (GC) strategies; however, owing to regional differences in the frequency and clinical characteristics of AAV subtypes, contemporary real-world evidence on long-term outcomes in Japanese patient populations remains limited.ObjectivesThe primary outcome was to elucidate subtype-specific clinical characteristics and five-year overall and relapse-free survival in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Secondary outcomes included temporal changes in treatment practices and prognosis, stratified by year of diagnosis.MethodsWe conducted a multicentre retrospective study using data from the REVEAL cohort. A total of 460 newly diagnosed, treatment-naïve cases were included (microscopic polyangiitis (MPA), n = 283; granulomatosis with polyangiitis (GPA), n = 66; eosinophilic granulomatosis with polyangiitis (EGPA), n = 111). Clinical characteristics, five-year relapse-free and overall survival were evaluated. To assess temporal changes in treatment practices and prognosis, patients were stratified by median year of diagnosis (2018) into pre-2018 and post-2019 groups.ResultsMPA showed the poorest prognosis among AAV subtypes, with a five-year overall survival rate of 67.6%. Older age and impaired renal function were independently associated with increased mortality (P < 0.001 and P = 0.0079, respectively). Over time, GC exposure was significantly reduced in the post-2019 group (P = 0.012), accompanied by fewer infection-related hospitalisations (P < 0.001). However, five-year overall and relapse-free survival did not differ between the pre-2018 and post-2019 groups. Notably, BVAS at 6 and 12 months were significantly higher (P = 0.0070 and P = 0.0057, respectively), and vasculitis-related mortality was more frequent in the post-2019 group (P = 0.0057).ConclusionMPA remained the AAV subtype with the poorest prognosis. Although GC exposure has decreased in recent years, this trend was not associated with improved clinical outcomes in the present cohort.

    2026Frontiers in immunology(2026)引用:1
    引用
    AI阅读
    加入学术空间
    3Serial Ultrastructural or Proteomic Observations in Light- and Heavy-Chain Deposition Disease
    Seiji Kakiuchi,Ikumi Takagi, Naru Tomigaki, Akimasa Sakamoto, Shutaro Fujioka, Isamu Harima, Hiroaki Akiyama, Ryotaro Niwa, Yoko Kozuki, Yoshiharu Miyata,Nobuko Iwata,Shigeo Hara,
    2026Kidney international reports(2026)引用:1
    引用
    AI阅读
    加入学术空间
    4
    裕一 寺西
    2026Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology)(2026)
    引用
    AI阅读
    加入学术空间
    5WCN26-8022 A CASE OF PRIMARY HYPERPARATHYROIDISM IN WHICH CALCIMIMETICS WAS INEFFECTIVE BUT BISPHOSPHONATE ALONE WAS EFFECTIVE
    Kodo Tomida, Marina Toda, Yutaro Hirata, Kaori Takaori, Koki Hattori
    2026Kidney International Reports(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 787 篇论文

    合作机构(100)

    神户大学合作论文 92
    大阪市立大学合作论文 72
    Osaka City General Hospital合作论文 58
    大阪府済生会中津病院合作论文 52
    东京大学合作论文 52
    京都大学合作论文 49
    大阪大学合作论文 44
    京都府立医科大学合作论文 35
    近畿大学合作论文 22
    和歌山医科大学合作论文 21

    机构统计